MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Late-onset cerebellar ataxia revealing a Pantothenate-kinase-associated neurodegeneration

    S. Laroussi, S. Sakka, S. Daoud, N. Bouattour, K. Moalla, N. Farhat, M. Damak, C. Mhiri (Sfax, Tunisia)

    Objective: Recall a case of genetic late-onset cerebellar ataxia with a specific clinical and radiological feature highly suggestive of Pantothenate-kinase-associated neurodegeneration(PKAN). Background: Cerebellar ataxia is…
  • 2023 International Congress

    Impaired Nt-acetylation and the Golgi, a new disease mechanism leading to autosomal recessive primary familial brain calcifications

    V. Chelban, H. Aksnes, L. Lamonica, R. Maroofian, L. Seabra, P. Devic, J. Vandrovcova, D. Murphy, A. Pagnamenta, N. Wood, R. Horvath, A. Ernst, J. Rothman, M. Mcentagart, Y. Crow, G. Nicolas, T. Arnesen, H. Houlden (London, United Kingdom)

    Objective: To identify new disease-gene in unsolved autosomal recessive primary familial brain calcifications. Background: Primary familial brain calcification (PFBC) is characterized by calcium deposition in the brain,…
  • 2023 International Congress

    Spinocerebellar Ataxia Autosomal Recessive Type 10 Misdiagnosed as a Multiple System Atrophy Type C: a Case Report.

    S. Gallo, M. Fabbri, F. Ory-Magne, O. Rascol (Toulouse, France)

    Objective: Spinocerebellar ataxia autosomal recessive type 10 (SCAR 10) is a very rare cause of slowly progressive cerebellar ataxia caused by mutations of ANO10 gene…
  • 2023 International Congress

    Parkinson’s disease management in the community

    L. Ambrosio, MV. Navarta, D. Kunkel, A. Pedraz-Marcos, A. Palmar-Santos, A. Haahr, LB. Vester, LK. Bragstad, TL. Nielsen, NB. Kruse, EG. Hjelle, SB. Haavaag, MC. Portillo (Southampton, United Kingdom)

    Objective: To explore perceptions of people with Parkinson's disease and family carers about the use and impact of health and social care services, community and…
  • 2023 International Congress

    Regional Pain Syndromes- A potential clinical biomarker of Prodromal Parkinson’s Disease

    M. Kumar (Kharagpur, India)

    Objective: To investigate whether regional pain syndromes can be an early clinical biomarker for prodromal PD without motor signs Background: The disease-related changes in Parkinson's…
  • 2023 International Congress

    Effects of NE3107 anti-inflammatory treatment on motor activity and neurodegenerative features of Parkinson’s disease in a marmoset monkey model

    I. Philippens, C. Ahlem, C. Reading (Antwerp, Belgium)

    Objective: To demonstrate the effects of an oral, anti-inflammatory agent, NE3107, on motor activity, levodopa-induced dyskinesia (LID) induction, and neuron survival in a marmoset model…
  • 2023 International Congress

    PD-PRIDE: Healthcare experiences of people identifying as LGBTQ+ with Parkinson disease: A qualitative study preliminary analysis

    T. Mcisaac, K. Sutton, P. Kalcic, M. Mussack, H. Shill (Phoenix, USA)

    Objective: To identify the lived experience and perspectives on healthcare access and equity of people with Parkinson disease (PwP) identifying as lesbian, gay, bisexual, transgender,…
  • 2023 International Congress

    Synaptic density and α-synuclein oligomers in skin biopsies: differences between idiopathic and GBA-linked Parkinson’s disease

    E. Contaldi, S. Mazzetti, M. Basellini, V. Ferri, E. Cereda, I. Isaias, G. Pezzoli, G. Cappelletti (Milan, Italy)

    Objective: To compare α-synuclein oligomers and synaptic density (SD) in skin biopsies from PD and GBA-PD. Background: Previous research [1] reported α-synuclein oligomers within synaptic terminals of autonomic fibers in…
  • 2023 International Congress

    Serotonin Coma: An Antipodal emergency

    K C. Chudasama, V J. Jhala (Rajkot, India)

    Objective: To highlight the severity of Serotonin syndrome precipitated in a Psychiatric patient on two unique serotonergic medications leading to a comatose state. Background: Serotonin…
  • 2023 International Congress

    STRAT-PARK: a biomarker and stratification initiative for Parkinson’s disease

    K. Stige, S. Kverneng, S. Sharma, GO. Skeie, E. Sheard, M. Søgnen, S. Af Geijerstam, T. Vetås, C. Dölle, F. Dick, A. Wahlvåg, E. Berntsen, F. Riemer, P. Goa, K. Haugarvoll, S. Buch, D. Reese, D. Babiker, Y. Mahdi, T. Wade, G. Miranda, J. Ganguly, Y. Tamilselvam, J. Chai, S. Bansal, D. Aur, M. Haacke, M. Jog, C. Tzoulis (Trondheim, Norway)

    Objective: The STRAT-PARK initiative aims to stratify Parkinson’s disease (PD) according to underlying molecular mechanisms, and to develop clinically applicable biomarkers for patient stratification. Background:…
  • « Previous Page
  • 1
  • …
  • 75
  • 76
  • 77
  • 78
  • 79
  • …
  • 186
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • #24187 (not found)
  • #29526 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • “Striatal Hand Signs” and early diagnosis of Parkinson's Disease: The “Monkey-Wrench Sign”.
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley